Cargando…
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity
Cancer cells evade T cell-mediated killing through tumour–immune interactions whose mechanisms are not well understood(1,2). Dendritic cells (DCs), especially type-1 conventional DCs (cDC1s), mediate T cell priming and therapeutic efficacy against tumours(3). DC functions are orchestrated by pattern...
Autores principales: | Guo, Chuansheng, You, Zhiyuan, Shi, Hao, Sun, Yu, Du, Xingrong, Palacios, Gustavo, Guy, Cliff, Yuan, Sujing, Chapman, Nicole M., Lim, Seon Ah, Sun, Xiang, Saravia, Jordy, Rankin, Sherri, Dhungana, Yogesh, Chi, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396969/ https://www.ncbi.nlm.nih.gov/pubmed/37407815 http://dx.doi.org/10.1038/s41586-023-06299-8 |
Ejemplares similares
-
Glutamine Synthetase: Localization Dictates Outcome
por: Castegna, Alessandra, et al.
Publicado: (2018) -
Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage
por: Bajana, Sandra, et al.
Publicado: (2020) -
Mevalonate metabolism–dependent protein geranylgeranylation regulates thymocyte egress
por: Du, Xingrong, et al.
Publicado: (2019) -
The Glutamine Transporter Slc38a1 Regulates GABAergic Neurotransmission and Synaptic Plasticity
por: Qureshi, Tayyaba, et al.
Publicado: (2019) -
Lipid signalling enforces T(reg) cell functional specialization in tumours
por: Lim, Seon Ah, et al.
Publicado: (2021)